What’s Behind the Surge in Pharmaceutical Deals?
Aug. 25 (Bloomberg) –- Bloomberg’s Shannon Pettypiece discusses Roche’s $8.3 billion offer for InterMune and big pharmaceutical deals. She speaks on “Bottom Line.” (Source: Bloomberg)
Most Recent Videos
China Said Drafting Asset Management Risk Restrictions
57:39 - China’s financial regulators are drafting new rules for the country’s asset-management products, with a view to reducing financial-sector risk by dispelling perceptions they are guaranteed by the government, according to people familiar with the matter. Bloomberg's Rosalind Chin reports on "Bloomberg Daybreak: Asia." (Source: Bloomberg)